These findings suggested that NMNAT2 could be involved in colorectal cancer development through a P53-mediated mechanism and that NMNAT2 expression could be enhanced through SIRT6 downregulation (although such a role for SIRT6 in NMNAT2 expression regulation remains to be confirmed) [111,112]. The gene discussed is SIRT6; the disease is colorectal cancer.